Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai Volunteers
TCTR20250708002Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of apixaban in venous thromboembolism (VTE), Atrial fibrillation (AFib) and pulmonary embolism (PE) (2 arms), sponsored by International Bio Service. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)pulmonary embolism (PE)
Beyond the preview
Go deeper on TCTR20250708002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250708002.